Literature DB >> 10984284

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies.

J M Chan1, M J Stampfer, E Giovannucci, J Ma, M Pollak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984284     DOI: 10.1016/s1096-6374(00)90015-7

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


× No keyword cloud information.
  14 in total

Review 1.  Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan.

Authors:  Valter D Longo; Satchidananda Panda
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

2.  Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.

Authors:  Nagi B Kumar; Karen Besterman-Dahan; Loveleen Kang; Julio Pow-Sang; Ping Xu; Kathy Allen; Diane Riccardi; Jeffrey P Krischer
Journal:  Clin Med Urol       Date:  2008-04-16

Review 3.  Fasting: molecular mechanisms and clinical applications.

Authors:  Valter D Longo; Mark P Mattson
Journal:  Cell Metab       Date:  2014-01-16       Impact factor: 27.287

Review 4.  MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans.

Authors:  J Jones; W Grizzle; H Wang; C Yates
Journal:  Biotech Histochem       Date:  2013-08-01       Impact factor: 1.718

5.  Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.

Authors:  R Palmqvist; G Hallmans; S Rinaldi; C Biessy; R Stenling; E Riboli; R Kaaks
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 6.  Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-04-25       Impact factor: 2.506

7.  Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

Authors:  Aruna V Sarma; Rodney L Dunn; Leslie A Lange; Anna Ray; Yunfei Wang; Ethan M Lange; Kathleen A Cooney
Journal:  Prostate       Date:  2008-02-15       Impact factor: 4.104

Review 8.  Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Authors:  Kevin C J Yuen; Anthony P Heaney; Vera Popovic
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

9.  Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Authors:  Leah S Lyons; Shuyun Rao; Wayne Balkan; Joanne Faysal; Carol A Maiorino; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2007-12-13

10.  Automated 3D-Printed Microfluidic Array for Rapid Nanomaterial-Enhanced Detection of Multiple Proteins.

Authors:  Karteek Kadimisetty; Spundana Malla; Ketki S Bhalerao; Islam M Mosa; Snehasis Bhakta; Norman H Lee; James F Rusling
Journal:  Anal Chem       Date:  2018-05-31       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.